UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036418 |
|---|---|
| Receipt number | R000041492 |
| Scientific Title | Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatine |
| Date of disclosure of the study information | 2019/04/05 |
| Last modified on | 2020/10/05 09:22:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatine
Acronym
Hemolysis of end stage renal disease
Scientific Title
Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatine
Scientific Title:Acronym
Hemolysis of end stage renal disease
Region
| Japan |
Condition
Condition
End stage renal disease
Classification by specialty
| Cardiology | Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To Elucidate a hemolysis in participants with end stage renal disease
Basic objectives2
Others
Basic objectives -Others
Evaluation of mechanism
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Severity of hemolysis between hemodialysis and peritoneal dialysis
Key secondary outcomes
Comparison of long-term prognosis with all-cause death between end stage renal disease participants with and without hemolysis
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients who received hemodialysis and peritoneal dialysis
Key exclusion criteria
Patients with malignant tumor
Patients with auto immune hemolytic anemia
Patients who received transfusion within 3 months
Patients with myelodysplastic syndromes
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | Koichiro |
| Middle name | |
| Last name | Matsumura |
Organization
Kansai Medical University Medical Center
Division name
Department of Cardiology
Zip code
570-8507
Address
10-15, Fumizono-cho, Moriguchi, Osaka Japan
TEL
+81-6-6992-1001
kmatsumura1980@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Shinobu |
| Middle name | |
| Last name | Bandou |
Organization
Kansai Medical University Medical Center
Division name
Department of Cardiology
Zip code
570-8507
Address
10-15, Fumizono-cho, Moriguchi, Osaka Japan
TEL
+81-6-6992-1001
Homepage URL
bandoshi@takii.kmu.ac.jp
Sponsor or person
Institute
Kansai Medical University Medical Center
Institute
Department
Personal name
Funding Source
Organization
Nakatani foundation
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kansai Medical University Medical Center
Address
10-15, Fumizono-cho, Moriguchi, Osaka Japan
Tel
+81-6-6992-1001
bandoshi@takii.kmu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 04 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
69
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2019 | Year | 04 | Month | 02 | Day |
Date of IRB
| 2019 | Year | 04 | Month | 02 | Day |
Anticipated trial start date
| 2019 | Year | 04 | Month | 05 | Day |
Last follow-up date
| 2023 | Year | 04 | Month | 04 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
prospective observational analysis
Management information
Registered date
| 2019 | Year | 04 | Month | 05 | Day |
Last modified on
| 2020 | Year | 10 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041492
